4.7 Article

SOX9 modulates the expression of key transcription factors required for heart valve development

Journal

DEVELOPMENT
Volume 142, Issue 24, Pages 4340-4350

Publisher

COMPANY BIOLOGISTS LTD
DOI: 10.1242/dev.125252

Keywords

Transcriptional networks; SOX9; Heart valves; Proliferation; Transcription factor; Limb; ChIP-Seq; Genome; Mouse; Embryogenesis; RNA-Seq

Funding

  1. Heart and Stroke Foundation of Canada [G-14-0006139]
  2. Genome Canada
  3. Genome British Columbia

Ask authors/readers for more resources

Heart valve formation initiates when endothelial cells of the heart transform into mesenchyme and populate the cardiac cushions. The transcription factor SOX9 is highly expressed in the cardiac cushion mesenchyme, and is essential for heart valve development. Loss of Sox9 in mouse cardiac cushion mesenchyme alters cell proliferation, embryonic survival, and valve formation. Despite this important role, little is known about how SOX9 regulates heart valve formation or its transcriptional targets. Therefore, we mapped putative SOX9 binding sites by ChIP-Seq in E12.5 heart valves, a stage at which the valve mesenchyme is actively proliferating and initiating differentiation. Embryonic heart valves have been shown to express a high number of genes that are associated with chondrogenesis, including several extracellular matrix proteins and transcription factors that regulate chondrogenesis. Therefore, we compared regions of putative SOX9 DNA binding between E12.5 heart valves and E12.5 limb buds. We identified context-dependent and context-independent SOX9-interacting regions throughout the genome. Analysis of context-independent SOX9 binding suggests an extensive role for SOX9 across tissues in regulating proliferation-associated genes including key components of the AP-1 complex. Integrative analysis of tissue-specific SOX9-interacting regions and gene expression profiles on Sox9-deficient heart valves demonstrated that SOX9 controls the expression of several transcription factors with previously identified roles in heart valve development, including Twist1, Sox4, Mecom and Pitx2. Together, our data identify SOX9-coordinated transcriptional hierarchies that control cell proliferation and differentiation during valve formation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Exceptional response to combination ipilimumab and nivolumab in metastatic uveal melanoma: Insights from genomic analysis

Irene S. Yu, Kathleen Wee, Laura Williamson, Emma Titmuss, Jianghong An, Sheida Naderi-Azad, Corey Metcalf, Stephen Yip, Basil Horst, Steven J. M. Jones, Katherine Paton, Brad H. Nelson, Marco Marra, Janessa J. Laskin, Kerry J. Savage

Summary: The case report describes a 66-year-old woman with metastatic uveal melanoma who showed an exceptional treatment response to ipilimumab/nivolumab therapy. The patient had almost complete resolution of metastatic disease, except for partial regression in one liver metastasis. Whole-genome and transcriptome analysis revealed genetic alterations in T-cell responses and high levels of plasma cells in the tumor microenvironment. The patient also had several germline SNPs that may have contributed to the treatment response and development of vitiligo. Elevated BMI and vitiligo may be clinically relevant factors for predicting response to immune checkpoint inhibitor therapy in uveal melanoma.

MELANOMA RESEARCH (2022)

Article Biotechnology & Applied Microbiology

NCBP2 and TFRC are novel prognostic biomarkers in oral squamous cell carcinoma

Rahul Arora, Logan Haynes, Mehul Kumar, Reid McNeil, Jahanshah Ashkani, Steven C. Nakoneshny, T. Wayne Matthews, Shamir Chandarana, Robert D. Hart, Steven J. M. Jones, Joseph C. Dort, Doha Itani, Ayan Chanda, Pinaki Bose

Summary: There is a lack of prognostic biomarkers and targeted therapeutics for oral squamous cell carcinoma (OSCC). However, amplification of the chromosomal segment 3q22-3q29 is observed in many epithelial cancers, including OSCC. Through an integrative analysis, we identified NCBP2 and TFRC as potential prognostic biomarkers for HPV-negative OSCC, and showed that NCBP2 depletion can inhibit OSCC cell proliferation, migration, and invasion.

CANCER GENE THERAPY (2023)

Article Oncology

Development of resistance to FGFR inhibition in urothelial carcinoma via multiple pathways in vitro

Geoffrey A. Pettitt, Carolyn D. Hurst, Zubeda Khan, Helen R. McPherson, Matthew C. Dunning, Olivia Alder, Fiona M. Platt, Emma V. Black, Julie E. Burns, Margaret A. Knowles

Summary: Resistance to FGFR inhibitors is common in bladder cancer, and various molecular profiles and mechanisms contribute to this resistance. Personalized therapy for FGFR-driven cancers is challenging due to the heterogeneity in resistance mechanisms and the persistence of resistant cell populations.

JOURNAL OF PATHOLOGY (2023)

Article Biochemistry & Molecular Biology

CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebase

Kilannin Krysiak, Arpad M. Danos, Jason Saliba, Joshua F. McMichael, Adam C. Coffman, Susanna Kiwala, Erica K. Barnell, Lana Sheta, Cameron J. Grisdale, Lynzey Kujan, Shahil Pema, Jake Lever, Sarah Ridd, Nicholas C. Spies, Veronica Andric, Andreea Chiorean, Damian T. Rieke, Kaitlin A. Clark, Caralyn Reisle, Ajay C. Venigalla, Mark Evans, Payal Jani, Hideaki Takahashi, Avila Suda, Peter Horak, Deborah Ritter, Xin Zhou, Benjamin J. Ainscough, Sean Delong, Chimene Kesserwan, Mario Lamping, Haolin Shen, Alex R. Marr, My H. Hoang, Kartik Singhal, Mariam Khanfar, Brian Li, Wan-Hsin Lin, Panieh Terraf, Laura B. Corson, Yasser Salama, Katie M. Campbell, Kirsten M. Farncombe, Jianling Ji, Xiaonan Zhao, Xinjie Xu, Rashmi Kanagal-Shamanna, Ian King, Kelsy C. Cotto, Zachary L. Skidmore, Jason R. Walker, Jinghui Zhang, Aleksandar Milosavljevic, Ronak Y. Patel, Rachel H. Giles, Raymond H. Kim, Lynn M. Schriml, Elaine R. Mardis, Steven J. M. Jones, Gordana Raca, Shruti Rao, Subha Madhavan, Alex H. Wagner, Malachi Griffith, Obi L. Griffith

Summary: CIVIC is a crowd-sourced, public domain knowledgebase that provides literature-derived evidence characterizing the clinical utility of cancer variants. It supports variant interpretation guidelines, increases interoperability with other variant resources, and promotes widespread dissemination of structured curated data. It currently includes over 300 contributors and represents >3200 variants in >470 genes from >3100 publications.

NUCLEIC ACIDS RESEARCH (2023)

Article Biochemistry & Molecular Biology

Defining the heterogeneity of unbalanced structural variation underlying breast cancer susceptibility by nanopore genome sequencing

Katherine Dixon, Yaoqing Shen, Kieran O'Neill, Karen L. L. Mungall, Simon Chan, Steve Bilobram, Wei Zhang, Marjorie Bezeau, Alshanee Sharma, Alexandra Fok, Andrew J. J. Mungall, Richard Moore, Ian Bosdet, My Linh Thibodeau, Sophie Sun, Stephen Yip, Kasmintan A. A. Schrader, Steven J. M. Jones

Summary: Nanopore long-read sequencing accurately detects pathogenic copy number alterations in cancer susceptibility genes and reveals unforeseen allelic heterogeneity and mechanisms of recurrent deletions. Integrating read-based and statistical phasing helps define extended haplotypes associated with founder alleles. Long-read sequencing is a sensitive method for characterizing private, recurrent and founder structural variants underlying breast cancer susceptibility.

EUROPEAN JOURNAL OF HUMAN GENETICS (2023)

Article Biochemistry & Molecular Biology

Immune Activation following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study

E. Titmuss, K. Milne, M. R. Jones, T. Ng, J. T. Topham, S. D. Brown, D. F. Schaeffer, S. Kalloger, D. Wilson, R. D. Corbett, L. M. Williamson, K. Mungall, A. J. Mungall, R. A. Holt, B. H. Nelson, S. J. M. Jones, J. Laskin, H. J. Lim, M. A. Marra

Summary: The POG program at BC Cancer identified specific alterations in colorectal cancer using whole genome and transcriptome analysis, and successfully treated a patient with irbesartan, an antihypertensive drug, resulting in a profound and durable response. Analysis showed an increase in immune signaling and infiltrating immune cells, particularly CD8+ T cells, in the relapsed tumor, suggesting an activated immune response contributed to the anti-tumor effect.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Gastroenterology & Hepatology

Fetal liver development and implications for liver disease pathogenesis

Jeremy Lotto, Tabea L. Stephan, Pamela A. Hoodless

Summary: Advancements in single-cell technologies and lineage tracing have enhanced our understanding of liver development. This review explores the formation of different types of liver cells and highlights the similarities between early liver development and the pathogenesis of liver injury. The research has significantly advanced our knowledge of cell differentiation, fate decisions, and the signaling microenvironment in liver development. This understanding also provides insights into liver disease and cancer and offers potential for improving regenerative medicine strategies.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2023)

Article Oncology

Mitogen-induced defective mitosis transforms neural progenitor cells

Hiba K. Omairi, Cameron J. Grisdale, Mathieu Meode, Alexandra K. Bohm, Sophie Black, Nancy J. Adam, Cassidy P. Chapman, Tatiana Maroilley, John J. Kelly, Maja Tarailo-Graovac, Steven J. M. Jones, Michael D. Blough, John Gregory Cairncross

Summary: This study reveals that PDGFA fails to induce the expression of kinetochore and spindle assembly checkpoint genes, leading to defective mitosis in neural progenitor cells (NPCs). Surviving cells with unstable genomes accumulate chromosomal rearrangements and give rise to tumorigenic NPCs with recurrent gains and losses of chromosomal regions. This work provides new insights into the mechanisms underlying the development of glioblastoma.

NEURO-ONCOLOGY (2023)

Article Biochemistry & Molecular Biology

The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responses

Zhiping Li, Xuanmao Jiao, A. Gordon Robertson, Gabriele Di Sante, Anthony W. Ashton, Agnese DiRocco, Min Wang, Jun Zhao, Sankar Addya, Chenguang Wang, Peter A. McCue, Andrew P. South, Carlos Cordon-Cardo, Runzhi Liu, Kishan Patel, Rasha Hamid, Jorim Parmar, James B. DuHadaway, Steven J. M. Jones, Mathew C. Casimiro, Nikolaus Schultz, Andrew Kossenkov, Lai Yee Phoon, Hao Chen, Li Lan, Yunguang Sun, Kenneth A. Iczkowski, Hallgeir Rui, Richard G. Pestell

Summary: Prostate cancer, the second leading cause of death in American men, is found to be associated with the deletion of DACH1 gene, which may define a specific subtype of the disease requiring tailored therapies.

ONCOGENE (2023)

Article Multidisciplinary Sciences

macroH2A2 antagonizes epigenetic programs of stemness in glioblastoma

Ana Nikolic, Francesca Maule, Anna Bobyn, Katrina Ellestad, Seungil Paik, Sajid A. Marhon, Parinaz Mehdipour, Xueqing Lun, Huey-Miin Chen, Claire Mallard, Alexander J. Hay, Michael J. Johnston, Christopher J. Gafuik, Franz J. Zemp, Yaoqing Shen, Nicoletta Ninkovic, Katalin Osz, Elodie Labit, N. Daniel Berger, Duncan K. Brownsey, John J. Kelly, Jeff Biernaskie, Peter B. Dirks, Darren J. Derksen, Steven J. M. Jones, Donna L. Senger, Jennifer A. Chan, Douglas J. Mahoney, Daniel D. De Carvalho, Marco Gallo

Summary: The histone variant macroH2A2 controls an epigenetic mechanism of self-renewal and suggests new treatment approaches for glioblastoma patients.

NATURE COMMUNICATIONS (2023)

Article Genetics & Heredity

Population-size history inferences from the coho salmon (Oncorhynchus kisutch) genome

Eric B. Rondeau, Kris A. Christensen, David R. Minkley, Jong S. Leong, Michelle T. T. Chan, Cody A. Despins, Anita Mueller, Dionne Sakhrani, Carlo A. Biagi, Quentin Rougemont, Eric Normandeau, Steven J. M. Jones, Robert H. Devlin, Ruth E. Withler, Terry D. Beacham, Kerry A. Naish, Jose M. Yanez, Roberto Neira, Louis Bernatchez, William S. Davidson, Ben F. Koop

Summary: The coho salmon populations in North America have significantly declined, and analysis of genomic data suggests bottleneck events after glacial retreat as a possible cause. A chromosome-level genome assembly and genome resequencing of 83 coho salmon were performed to aid in stock management and conservation efforts.

G3-GENES GENOMES GENETICS (2023)

Article Oncology

Homologous recombination deficiency signatures in gastrointestinal and thoracic cancers correlate with platinum therapy duration

Erica S. S. Tsang, Veronika Csizmok, Laura M. M. Williamson, Erin Pleasance, James T. T. Topham, Joanna M. M. Karasinska, Emma Titmuss, Intan Schrader, Stephen Yip, Basile Tessier-Cloutier, Karen Mungall, Tony Ng, Sophie Sun, Howard J. J. Lim, Jonathan M. M. Loree, Janessa Laskin, Marco A. A. Marra, Steven J. M. Jones, David F. F. Schaeffer, Daniel J. J. Renouf

Summary: Emerging evidence suggests a predictive role of homologous recombination deficiency (HRD) in gastrointestinal and thoracic malignancies. In this study, whole genome and transcriptomic data were reviewed to evaluate HRD scores and single base substitution 3 (SBS3) in advanced GI and thoracic cancers. The association between HRD and time to progression on platinum (TTPp) was examined, and it was found that SBS3 was more strongly associated with TTPp in GI malignancies. Tumors with gBRCA1/2 mutations and a somatic second alteration showed high SBS3 and HRD scores, indicating potential therapeutic targets.

NPJ PRECISION ONCOLOGY (2023)

Article Oncology

A generalizable machine learning framework for classifying DNA repair defects using ctDNA exomes

Elie J. Ritch, Cameron Herberts, Evan W. Warner, Sarah W. S. Ng, Edmond M. Kwan, Jack V. W. Bacon, Cecily Q. Bernales, Elena Schonlau, Nicolette M. Fonseca, Veda N. Giri, Corinne Maurice-Dror, Gillian Vandekerkhove, Steven J. M. Jones, Kim N. N. Chi, Alexander W. Wyatt

Summary: Specific classes of DNA damage repair defects can increase sensitivity to emerging therapies for metastatic prostate cancer. However, biomarker approaches based on DDR gene sequencing are not accurate predictors of DDR deficiency or treatment efficacy. We developed a machine learning approach using whole-exome sequencing data to simultaneously identify multiple types of DDR deficiencies in metastatic prostate cancer.

NPJ PRECISION ONCOLOGY (2023)

Article Genetics & Heredity

HostSeq: a Canadian whole genome sequencing and clinical data resource

S. Yoo, E. Garg, L. T. Elliott, R. J. Hung, A. R. Halevy, J. D. Brooks, S. B. Bull, F. Gagnon, C. M. T. Greenwood, J. F. Lawless, A. D. Paterson, L. Sun, M. H. Zawati, J. Lerner-Ellis, R. J. S. Abraham, I Birol, G. Bourque, J-m Garant, C. Gosselin, J. Li, J. Whitney, B. Thiruvahindrapuram, J-a Herbrick, M. Lorenti, M. S. Reuter, O. O. Adeoye, S. Liu, U. Allen, F. P. Bernier, C. M. Biggs, A. M. Cheung, J. Cowan, M. Herridge, D. M. Maslove, B. P. Modi, V Mooser, S. K. Morris, M. Ostrowski, R. S. Parekh, G. Pfeffer, O. Suchowersky, J. Taher, J. Upton, R. L. Warren, R. S. M. Yeung, N. Aziz, S. E. Turvey, B. M. Knoppers, M. Lathrop, S. J. M. Jones, S. W. Scherer, L. J. Strug

Summary: HostSeq was launched in April 2020 to integrate whole genome sequencing data and clinical information of 10,000 Canadians infected with SARS-CoV-2. It aims to support research communities in understanding disease risk factors and developing interventions. HostSeq is a collaboration among 13 epidemiological studies across five provinces in Canada, providing aggregated data through two portals and individual-level data for global health research.

BMC GENOMIC DATA (2023)

Article Cell Biology

Parent-of-origin detection and chromosome-scale haplotyping using long-read DNA methylation sequencing and Strand-seq

Vahid Akbari, Vincent C. T. Hanlon, Kieran O'Neill, Louis Lefebvre, Kasmintan A. Schrader, Peter M. Lansdorp, Steven J. M. Jones

Summary: Researchers have developed a method to determine the parent of origin for all human autosomes by integrating methylation-detecting nanopore sequencing with Strand-seq data. This method has the potential to improve the diagnosis and management of genetic diseases.

CELL GENOMICS (2023)

No Data Available